CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.18 USD | -0.22% |
|
-3.68% | -14.92% |
| 04-26 | CVS Omnicare staff in Las Vegas vote to join new union | RE |
| 04-26 | Morgan Stanley Cuts Price Target on CVS Health to $85 From $92 | MT |
| Sales 2024 * | 371B 29,685B | Sales 2025 * | 393B 31,451B | Capitalization | 84.68B 6,779B |
|---|---|---|---|---|---|
| Net income 2024 * | 8.91B 713B | Net income 2025 * | 9.81B 785B | EV / Sales 2024 * | 0.36 x |
| Net Debt 2024 * | 48.01B 3,843B | Net Debt 2025 * | 43.34B 3,469B | EV / Sales 2025 * | 0.33 x |
| P/E ratio 2024 * |
9.78
x | P/E ratio 2025 * |
8.66
x | Employees | 259,500 |
| Yield 2024 * |
3.93% | Yield 2025 * |
4.19% | Free-Float | 72.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | -0.22% | ||
| 1 week | -3.68% | ||
| Current month | -15.77% | ||
| 1 month | -15.31% | ||
| 3 months | -7.97% | ||
| 6 months | -1.18% | ||
| Current year | -14.92% |
1 week
66.75
70.21
1 month
66.7580.75
Current year
66.7583.25
1 year
64.4183.25
3 years
64.41111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 27/11/18 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 31/01/22 |
David Falkowski
CMP | Compliance Officer | - | 28/02/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 19/01/11 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 27/11/18 |
Mary Schapiro
BRD | Director/Board Member | 68 | 09/05/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 18 M€ | +3.79% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 67.18 | -0.22% | 6,396,438 |
| 25/04/24 | 67.33 | -0.65% | 8,918,219 |
| 24/04/24 | 67.77 | -1.07% | 8,651,960 |
| 23/04/24 | 68.5 | -1.62% | 8,450,704 |
| 22/04/24 | 69.63 | -0.17% | 5,701,582 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
01/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
67.18
USD
Average target price
88.15
USD
Spread / Average Target
+31.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- CVS Stock
